In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?
2008

Does the Size of an Individual Trial Still Matter?

publication Evidence: moderate

Author Information

Author(s): Gordon H. Guyatt, Edward J. Mills, Diana Elbourne

Primary Institution: McMaster University

Hypothesis

Does the sample size calculation for an individual trial still matter in the era of systematic reviews?

Conclusion

Individual trials, even large ones, rarely provide definitive answers, and systematic reviews are necessary for robust conclusions.

Supporting Evidence

  • Systematic reviews are now considered the top of the hierarchy of clinical evidence.
  • Small trials can be misleading and may not provide definitive answers.
  • Funding for large trials is often limited and primarily from industry sources.
  • Many potential trials are abandoned due to unrealistic sample size requirements.
  • Peer-reviewed granting agencies should ask more appropriate questions regarding trial importance.

Takeaway

This study says that just because a trial is big doesn't mean it will give clear answers, and we need to look at many trials together to really understand things.

Potential Biases

Small trials may mislead due to selection bias and may stifle further investigation.

Limitations

The reliance on sample size calculations may lead to the abandonment of potentially valuable trials.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication